Currently available drug options for the management of IBD

Autor:	Mark Wilkinson, Sally Parry
Rok vydání:	2009
Předmět:	Drug Ibd clinical medicine.medical_specialty Pathology business.industry media_common.quotation_subject Alternative medicine Pharmacology (nursing) Disease Medicine Pharmacology (medical) business Intensive care medicine Older people media_common
Zdroj:	Prescriber. 20:16-30
ISSN:	1931-2253 0959-6682
DOI:	10.1002/psb.561
Popis:	Summary The exact cause of IBD is unknown, but it commonlyaffects young as well as older people, and its chronic-ity and potential for complications impact greatly onthe lives of those affected. As no single therapy is uni-formly effective, it is important to discuss treatmentsand possible future therapies with patients at the timeof diagnosis. Generally, so-called disease-modifyingdrugs, such as the immunomodulators and the bio-logicals, are being used earlier than hitherto in anattempt to modify the long-term course of the disease. Hospitals may be fortunate enough to have desig-nated IBD clinical nurse specialists for ongoing adviceand support. Resources to aid patient educationshould be provided and include patient informationleaflets and information about IBD support groups(see Resources). References 1. Mimura T, et al . Gut 2004;53:108-14.2. Kruis W, et al . Gut 2004;53:1617-23.3. Simopoulos AP. J Am Coll Nutr 2002;21(6):495-505.4. MacLean CH, et al . Am J Clin Nutr 2005;82:611-9.5. Marteau P
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a533b78cdb02d44fc1964ba0b670b464 https://doi.org/10.1002/psb.561 Zobrazit plný text záznamu Plný text